These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21743980)

  • 1. Neoadjuvant chemotherapy increases the rate of breast conservation in lobular-type breast cancer patients.
    Fitzal F; Mittlboeck M; Steger G; Bartsch R; Rudas M; Dubsky P; Riedl O; Jakesz R; Gnant M
    Ann Surg Oncol; 2012 Feb; 19(2):519-26. PubMed ID: 21743980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study.
    Fitzal F; Riedl O; Mittlböck M; Dubsky P; Bartsch R; Steger G; Jakesz R; Gnant M
    Breast Cancer Res Treat; 2011 May; 127(1):121-8. PubMed ID: 20848185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncologic safety of breast-conserving surgery compared to mastectomy in patients receiving neoadjuvant chemotherapy for locally advanced breast cancer.
    Cho JH; Park JM; Park HS; Park S; Kim SI; Park BW
    J Surg Oncol; 2013 Dec; 108(8):531-6. PubMed ID: 24115142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast-conserving surgery after neoadjuvant anthracycline-based chemotherapy for large breast tumors.
    Rouzier R; Mathieu MC; Sideris L; Youmsi E; Rajan R; Garbay JR; André F; Marsiglia H; Spielmann M; Delaloge S
    Cancer; 2004 Sep; 101(5):918-25. PubMed ID: 15329898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.
    Vo TN; Meric-Bernstam F; Yi M; Buchholz TA; Ames FC; Kuerer HM; Bedrosian I; Hunt KK
    Am J Surg; 2006 Oct; 192(4):552-5. PubMed ID: 16978974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic response to short intensified taxane-free neoadjuvant chemotherapy in patients with highly proliferative operable breast cancer.
    Le Tourneau C; Dettwiler S; Beuzeboc P; Alran S; Laurence V; Pierga JY; Fréneaux P; Sigal-Zafrani B; Diéras V; Vincent-Salomon A
    Am J Clin Oncol; 2012 Jun; 35(3):242-6. PubMed ID: 21358298
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
    Moran MS; Yang Q; Haffty BG
    Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
    Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy.
    Ataseven B; Lederer B; Blohmer JU; Denkert C; Gerber B; Heil J; Kühn T; Kümmel S; Rezai M; Loibl S; von Minckwitz G
    Ann Surg Oncol; 2015 Apr; 22(4):1118-27. PubMed ID: 25297900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
    Tafra L; Essner R; Brenner RJ; Giuliano AE
    Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.
    Levy A; Borget I; Bahri M; Arnedos M; Rivin E; Vielh P; Balleyguier C; Rimareix F; Bourgier C
    Breast J; 2014; 20(4):381-7. PubMed ID: 24890310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast conservative surgery after neoadjuvant chemotherapy in breast cancer patients: comparison of two tumor localization methods.
    Espinosa-Bravo M; Sao Avilés A; Esgueva A; Córdoba O; Rodriguez J; Cortadellas T; Mendoza C; Salvador R; Xercavins J; Rubio IT
    Eur J Surg Oncol; 2011 Dec; 37(12):1038-43. PubMed ID: 21940138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
    Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
    Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Success and failure of primary medical, nonoperative management in breast cancer.
    Schmid SM; Modlasiak AA; Myrick ME; Kilic N; Viehl CT; Schötzau A; Güth U
    Ann Surg Oncol; 2011 Aug; 18(8):2166-72. PubMed ID: 21311982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapy.
    Keskin S; Muslumanoglu M; Saip P; Karanlık H; Guveli M; Pehlivan E; Aydoğan F; Eralp Y; Aydıner A; Yavuz E; Ozmen V; Igci A; Topuz E
    Oncology; 2011; 81(1):30-8. PubMed ID: 21912195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.
    Poggi MM; Danforth DN; Sciuto LC; Smith SL; Steinberg SM; Liewehr DJ; Menard C; Lippman ME; Lichter AS; Altemus RM
    Cancer; 2003 Aug; 98(4):697-702. PubMed ID: 12910512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy.
    Jolly S; Kestin LL; Goldstein NS; Vicini FA
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):365-71. PubMed ID: 16965988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary operations are frequently required to complete the surgical phase of therapy in the era of breast conservation and sentinel lymph node biopsy.
    Mullenix PS; Cuadrado DG; Steele SR; Martin MJ; See CS; Beitler AL; Carter PL
    Am J Surg; 2004 May; 187(5):643-6. PubMed ID: 15135683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical procedures after neoadjuvant chemotherapy in operable breast cancer: results of the GEPARDUO trial.
    Loibl S; von Minckwitz G; Raab G; Blohmer JU; Dan Costa S; Gerber B; Eidtmann H; Petrich S; Hilfrich J; Jackisch C; du Bois A; Kaufmann M
    Ann Surg Oncol; 2006 Nov; 13(11):1434-42. PubMed ID: 16983592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.